INCOME STATEMENT (Quarterly GAAP In millions $) |
(Dec 31 2024) Q4 2024 |
(Sep 30 2024) Q3 2024 |
(Jun 30 2024) Q2 2024 |
(Mar 31 2024) Q1 2024 |
(Dec 31 2023) Q4 2023 |
Revenue From Contract With Customer Excluding Assessed Tax |
|
123.64 |
133.21 |
128.09 |
|
Revenue From Contract With Customer Excluding Assessed Tax |
|
- |
- |
- |
|
Other Revenue |
|
-0.96 |
-0.81 |
-0.01 |
|
Total Revenue |
151.21 |
122.68 |
132.40 |
128.08 |
139.50 |
Cost of Goods and Services Sold |
95.00 |
78.00 |
79.00 |
80.00 |
88.32 |
Gross
Profit |
56.21 |
44.68 |
53.40 |
48.08 |
51.18 |
Selling, Administration, Marketing |
34.83 |
26.70 |
24.14 |
24.94 |
24.94 |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Research and Development Expense |
6.93 |
5.44 |
5.99 |
5.22 |
5.97 |
Restructuring, Accretion & impairment charges |
0.40 |
- |
- |
- |
- |
Other operatinig exp. /-income |
4.08 |
0.00 |
0.00 |
0.00 |
0.00 |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Restructuring Costs |
1.67 |
1.09 |
0.64 |
0.07 |
3.81 |
Interest Expense Nonoperating |
-4.08 |
- |
- |
- |
- |
Total operating costs including COS |
138.83 |
111.23 |
109.77 |
110.22 |
123.04 |
Operating income/-loss
|
12.37 |
11.45 |
22.62 |
17.85 |
16.47 |
Other Deductions / - Income |
Interest expense |
1.26 |
0.41 |
0.42 |
0.43 |
0.45 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
1.26 |
0.41 |
0.42 |
0.43 |
0.45 |
Investment Income, Nonoperating |
8.50 |
-1.48 |
-1.15 |
-1.12 |
- |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
-4.77 |
1.33 |
0.47 |
-1.82 |
2.52 |
Total costs & expenses |
143.82 |
111.49 |
109.51 |
107.73 |
126.00 |
Income /-loss before income taxes |
7.39 |
11.19 |
22.88 |
20.35 |
13.50 |
Income taxes expenses/-benefit |
0.95 |
3.11 |
4.08 |
4.48 |
1.46 |
Income after income taxes |
6.43 |
8.08 |
18.81 |
15.87 |
12.04 |
Net income/-loss
of other equity |
0.00 |
- |
0.00 |
- |
0.00 |
Income/-loss
from cont. Ops. |
6.43 |
8.08 |
18.81 |
15.87 |
12.04 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
6.43 |
8.08 |
18.81 |
15.87 |
12.04 |
Noncontrolling interests |
0.48 |
- |
- |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
-1.80 |
8.08 |
18.81 |
15.87 |
12.04 |
EBIT |
8.65 |
11.60 |
23.30 |
20.79 |
13.95 |
EBITD |
14.35 |
15.24 |
26.74 |
24.47 |
17.30 |
EBITDA |
14.47 |
15.24 |
26.74 |
24.50 |
17.30 |